Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Baradaran

Showing results (561-570 of 707) with videos related to

Pageof 71
Sort By:
Journal of Cellular Physiology|June 28, 2020
Resistance mechanisms to immune checkpoints blockade by monoclonal antibody drugs in cancer immunotherapy: Focus on myelomaAlireza Isazadeh, Saba Hajazimian, Hamid Garshasbi, et al.
The British Journal of Nutrition|May 15, 2020
Dietary patterns and relative expression levels of <i>PPAR-γ</i>, <i>VEGF-A</i> and <i>HIF-1α</i> genes in benign breast diseases: case-control and consecutive case-series designsSanaz Asemani, Vahid Montazeri, Mitra Foroutan-Ghaznavi, et al.
Bioimpacts : BI|August 16, 2016
Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitroJalil Pirayesh Islamian, Mohsen Mohammadi, Behzad Baradaran, et al.
Genes|March 6, 2021
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient PrognosisBehzad Mansoori, Nicola Silvestris, Ali Mohammadi, et al.
Journal of Cellular Physiology|September 22, 2020
The oncogenic potential of NANOG: An important cancer induction mediatorBasira Najafzadeh, Zahra Asadzadeh, Rohollah Motafakker Azad, et al.
Advanced Pharmaceutical Bulletin|August 30, 2023
CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell MigrationSouzan Najafi, Zohreh Rahimi, Behzad Mansoori, et al.
Reviews in Medical Virology|June 6, 2020
Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysisAli Pormohammad, Saied Ghorbani, Alireza Khatami, et al.
Frontiers in Immunology|February 7, 2022
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized MedicineMahdi Abdoli Shadbad, Nima Hemmat, Vahid Khaze Shahgoli, et al.
Journal of Cellular Physiology|November 28, 2018
miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expressionBehzad Mansoori, Ali Mohammadi, Mehri Ghasabi, et al.
Photodiagnosis and Photodynamic Therapy|November 27, 2022
Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?Neda Rajabi, Fateme Mohammadnejad, Mohammad Amin Doustvandi, et al.
Pageof 71

Showing results (561-570 of 707) with videos related to

Sort By:
Pageof 71
Journal of Cellular Physiology|June 28, 2020
Resistance mechanisms to immune checkpoints blockade by monoclonal antibody drugs in cancer immunotherapy: Focus on myelomaAlireza Isazadeh, Saba Hajazimian, Hamid Garshasbi, et al.
The British Journal of Nutrition|May 15, 2020
Dietary patterns and relative expression levels of <i>PPAR-γ</i>, <i>VEGF-A</i> and <i>HIF-1α</i> genes in benign breast diseases: case-control and consecutive case-series designsSanaz Asemani, Vahid Montazeri, Mitra Foroutan-Ghaznavi, et al.
Bioimpacts : BI|August 16, 2016
Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitroJalil Pirayesh Islamian, Mohsen Mohammadi, Behzad Baradaran, et al.
Genes|March 6, 2021
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient PrognosisBehzad Mansoori, Nicola Silvestris, Ali Mohammadi, et al.
Journal of Cellular Physiology|September 22, 2020
The oncogenic potential of NANOG: An important cancer induction mediatorBasira Najafzadeh, Zahra Asadzadeh, Rohollah Motafakker Azad, et al.
Advanced Pharmaceutical Bulletin|August 30, 2023
CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell MigrationSouzan Najafi, Zohreh Rahimi, Behzad Mansoori, et al.
Reviews in Medical Virology|June 6, 2020
Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysisAli Pormohammad, Saied Ghorbani, Alireza Khatami, et al.
Frontiers in Immunology|February 7, 2022
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized MedicineMahdi Abdoli Shadbad, Nima Hemmat, Vahid Khaze Shahgoli, et al.
Journal of Cellular Physiology|November 28, 2018
miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expressionBehzad Mansoori, Ali Mohammadi, Mehri Ghasabi, et al.
Photodiagnosis and Photodynamic Therapy|November 27, 2022
Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?Neda Rajabi, Fateme Mohammadnejad, Mohammad Amin Doustvandi, et al.
Pageof 71